Navigation Links
Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy

ty of cerebral origin from receiving this clinically effective treatment," explained Dr. Terence Edgar of the Medical College of Wisconsin's Department of Neurology and senior author of the study. "Specifically, we found that the projected improvement in quality of life justifies the estimated five-year treatment cost based on well-established guidelines for cost-effectiveness."

Dr. Edgar and colleagues, including a team of health economists from United BioSource Corp. in Bethesda, Md., "used mathematical modeling and computer simulation to estimate the incremental cost per quality-adjusted life-year for identical cohorts of children treated with intrathecal baclofen or alternative therapy during a five-year episode of treatment," according to the study abstract. "On average, intrathecal baclofen therapy increased the five-year cost of treatment by $49,000 relative to alternative treatment. However, this was accompanied by an average gain of 1.2 quality-adjusted life-years. The net result was an incremental cost-effectiveness ratio of $42,000 per quality-adjusted life-year, a figure well (below) the $50,000 to $100,000 range that is widely accepted as offering good value for money."

Supported by Medtronic, this analysis of ITB Therapy's cost-effectiveness is the first in the context of the U.S. healthcare system.

"Cost-effectiveness is an important consideration in today's healthcare environment," said Dr. Richard E. Kuntz, M.D., senior vice president of Medtronic, Inc., and president of the company's Neurological business. "This study supports the cost-effectiveness of Medtronic ITB Therapy, an effective treatment for severe spasticity that has the potential to restore functional ability and a better quality of life to thousands of people every year."

Medtronic ITB Therapy is indicated for the management of severe spasticity of cerebral and spinal origin, including stroke, cerebral palsy, brain injury, spinal cord injury, and multiple sc
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... addition of the "Investment Analysis of the ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... the US medical device sector identifies the key ... venture capital investments, and mergers and acquisitions. ...
(Date:12/22/2014)... Cyberonics, Inc. (NASDAQ: CYBX ), a global leader ... today announced it will participate in the 33 rd ... in San Francisco . ... speak at 11:00 AM Pacific Time.  A live audio webcast ... Investor Relations link on the Cyberonics home page at ...
(Date:12/22/2014)... MARLBOROUGH, Mass , Dec. 22, 2014 /PRNewswire/ -- ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today issued the following open ... Geert Cauwenbergh , Dr. Med. Sc. ... few days a number of inaccurate statements posted ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... March 17 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... ended December 31, 2007, and provided an update,on the ... "During 2007 and the first quarter of 2008, we ... an important transitional year for,Alexza, as we initiate the ...
... Eye via,Ophthalmic Artery, WASHINGTON, March 17 ... -- a,deadly, inherited cancer of one or both ... having their eyes surgically removed (enucleated),according to the ... Society of,Interventional Radiology,s 33rd Annual Scientific Meeting. Advanced,retinoblastoma ...
Cached Medicine Technology:Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 2Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 3Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 4Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 5Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 6Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 7Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 8Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 9Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 10Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 11Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 12Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 13Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status 14New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases 2New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases 3New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases 4
(Date:12/24/2014)... 2014 Today, UWDress.com, the famous women’s dress ... gowns, and launched a site-wide wedding gown promotion. ... gowns in a more unexpected way, the collection should be ... in the global market, and they are available with custom ... offered at discounted prices, up to 75% off; most of ...
(Date:12/24/2014)... Oregon (PRWEB) December 24, 2014 ... Rehab sat down with Derek Fenwick, PT, MBA, ... changes that will stem from the passing of the ... (IMPACT Act). In this taping of the Infinicast, ... title XVIII of the Social Security Act to standardize ...
(Date:12/24/2014)... The holidays can be a challenge for people who suffer ... drinks. "This is the season in which many people ... David Dodick, chair of the American Migraine Foundation, said in ... think through food and beverage choices, to help reduce the ... of neurology at the Mayo Clinic in Scottsdale, Ariz. , ...
(Date:12/24/2014)... Adults who experienced childhood abuse or neglect have ... study published online Dec. 24 in the journal ... long-lasting effects, like associated medical and psychological conditions ... director of behavioral medicine at Montefiore Headache Center ... news release. "When managing patients with migraine, ...
(Date:12/24/2014)... 24, 2014 (HealthDay News) -- A lab technician with ... have been exposed to the Ebola virus in an ... up to a dozen other lab workers are being ... afternoon. The possible exposure occurred Monday when CDC ... of the potentially lethal virus to another CDC lab ...
Breaking Medicine News(10 mins):Health News:Buy Cheap Long Sleeve Wedding Gowns At UWDress.com 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:Expert Offers Tips for Preventing Holiday Migraines 2Health News:Abuse in Childhood Tied to Migraines in Adulthood 2Health News:CDC Monitors Lab Worker for Possible Ebola Exposure 2
... Guaranteed Healthcare, AFL-CIO Secretary Treasurer Richard Trumka to Keynote ... ... Patients, First Responders to Join Emotional September 11th Rally With ... Californians, OAKLAND, Calif., Sept. 6 The California Nurses,Association/National ...
... to Support EIF,s Women,s ... Cancer Research Fund, ... edition version of its all-new, eagerly-awaited 2008,C350 Sport Sedan to raise ... initiative developed in partnership with the Entertainment,Industry Foundation,s (EIF) Women,s Cancer ...
... will participate in a nationwide study to pinpoint the ... infection. , The objective of this trial is ... people who have MRSA, said David Karras, professor and ... Medicine and Hospital, who will lead the research efforts ...
... Tim McGraw and Friends, ... Presented by Anheuser-Busch Companies, NAPA, Calif., Sept. 6 ... on Friday, Nov. 2 at Grant,s Farm,the ancestral home of ... "Denim & Diamonds: An Evening with Tim McGraw and,Friends". Proceeds ...
... Predictive medicine company,PreMD Inc. (TSX: PMD; Amex: PME) ... U.S. Food and Drug Administration (FDA) regarding its,510(k) ... POC skin,cholesterol test. PreMD submitted the 510(k) application ... to obtain broader clearance in the assessment of,cardiovascular ...
... may open a window of vulnerability for developing binge ... according to a study from the University of North ... , In a long-term study of 100,000 pregnant Norwegian ... incidences of binge eating disorder that began during pregnancy. ...
Cached Medicine News:Health News:Hundreds of RNs from Across U.S. and World to Join California Nurses Association/NNOC National Convention 2Health News:Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenue's KEY TO THE CURE 2Health News:Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenue's KEY TO THE CURE 3Health News:Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenue's KEY TO THE CURE 4Health News:Temple Emergency Medicine receives $1.8M to find best MRSA treatment 2Health News:Temple Emergency Medicine receives $1.8M to find best MRSA treatment 3Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 2Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 3Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 4Health News:PreMD Provides Update on 510(k) Application for PREVU(x) POC 2Health News:Pregnancy may increase the risk of developing binge eating disorder 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: